← Leaderboards
Chang Yao
Nanovis, Llc
$2,073,710
Attributed
$2,073,710
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2010–15$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,073,710 · 4
By mechanism
R44$1,499,999 · 1
R43$573,711 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroMalignant NeoplasmsCostSuccessProceduresMechanicsFamily SuidaeGrowthGrantPublic Health RelevanceImplantNanotechnologyExcisionProgramsSafetyDesignInfectionAutologousCalciumAreaIntestinesGlycolic-Lactic Acid PolyesterCharacteristicsBladder Tissue
Grant awards (5)
Development and Commercialization of Nanostructured Resorbable Urogenital Grafts$677,696
R44 · FY2015 · CA · contact PI
Durable Biomechanical Stabilization of Spinal Fusion Segments Despite Pseudoarthrosis Using Spinal Implants with Nano and Micron Porous Hierarchical Structures in a Novel Non-Union Model$213,126
R43 · FY2015 · AR · contact PI
Spinal Pseudoarthrosis Mitigation Using Nano Devices$149,830
R43 · FY2015 · AG · contact PI
Development and Commercialization of Nanostructured Resorbable Urogenital Grafts$822,303
R44 · FY2014 · CA · contact PI
Creation of the First Nanostructured Synthetic Regenerative Bladder Graft Materia$210,755
R43 · FY2010 · CA · contact PI